Citadel Advisors’s GAN Ltd GAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-400
Closed -$728 14868
2024
Q4
$728 Hold
400
﹤0.01% 14279
2024
Q3
$708 Buy
+400
New +$659 ﹤0.01% 13965
2024
Q1
Sell
-97,300
Closed -$154K 14867
2023
Q4
$154K Sell
97,300
-2,000
-2% -$2.66K ﹤0.01% 10344
2023
Q3
$115K Sell
99,300
-3,500
-3% -$5.5K ﹤0.01% 10713
2023
Q2
$169K Sell
102,800
-1,500
-1% -$2.14K ﹤0.01% 10145
2023
Q1
$135K Buy
104,300
+4,800
+5% +$8.73K ﹤0.01% 10815
2022
Q4
$149K Sell
99,500
-19,800
-17% -$33.3K ﹤0.01% 10614
2022
Q3
$265K Sell
119,300
-59,800
-33% -$181K ﹤0.01% 9832
2022
Q2
$530K Buy
179,100
+26,300
+17% +$97.4K ﹤0.01% 8514
2022
Q1
$737K Sell
152,800
-10,900
-7% -$70.1K ﹤0.01% 8443
2021
Q4
$1.5M Sell
163,700
-89,900
-35% -$1.1M ﹤0.01% 6879
2021
Q3
$3.77M Buy
253,600
+101,700
+67% +$1.63M ﹤0.01% 4873
2021
Q2
$2.5M Sell
151,900
-51,300
-25% -$904K ﹤0.01% 6048
2021
Q1
$3.7M Sell
203,200
-7,000
-3% -$177K ﹤0.01% 4952
2020
Q4
$4.26M Buy
210,200
+106,600
+103% +$1.79M ﹤0.01% 3945
2020
Q3
$1.75M Buy
103,600
+12,100
+13% +$256K ﹤0.01% 4978
2020
Q2
$2.33M Buy
+91,500
New +$1.75M ﹤0.01% 4310

Other funds holding GAN

Citadel Advisors's GAN Position: Q1 2025 in Review

Citadel Advisors sold out of GAN Ltd (GAN) in Q1 2025, closing a stake of 42,611 shares — an estimated $77.6K sold.

Citadel Advisors first reported a position in GAN in Q3 2020 and held it in 16 quarters. The position peaked at $3.99M in Q2 2021. 53 funds tracked by Wall St. Rank hold GAN as of Q1 2025.

  • Citadel Advisors reported no remaining GAN Ltd position as of Q1 2025 after selling out during the quarter.
  • Citadel Advisors sold 42,611 GAN Ltd shares in Q1 2025, an estimated $77.6K.
  • Citadel Advisors first reported a position in GAN Ltd in Q3 2020 and held it in 16 quarters.
  • Citadel Advisors's GAN Ltd position peaked at $3.99M in Q2 2021.
  • 53 funds tracked by Wall St. Rank held GAN Ltd as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.